Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2013; 24(7): 837-838
DOI: 10.1055/s-0032-1318492
DOI: 10.1055/s-0032-1318492
letter
Synthesis of New Propargylated 1-Pyrindane Derivatives as Rasagiline Analogues
Further Information
Publication History
Received: 20 December 2012
Accepted after revision: 02 March 2013
Publication Date:
14 March 2013 (online)

Abstract
Rasagiline is a compound with important neuroprotective activity applicable to the treatment of neurodegenerative diseases. This work describes an easy and straightforward methodology to the synthesis of new propargylated rasagiline analogues derived from commercially available 6,7-dihydro-5H-cyclopenta[b]pyridine.
Key words
neuroprotective drugs - pyrindanes - Boekelheide rearrangement - Swern oxidation - reductive aminationSupporting Information
- for this article is available online at http://www.thieme-connect.com/ejournals/toc/synlett.
- Supporting Information
-
References and Notes
- 1a Aluf Y, Vaya J, Khatib S, Loboda Y, Finberg JP. M. Neuropharmacology 2013; 65: 48
- 1b Van der Schyf CJ, Geldenhuys WJ. Int. Rev. Neurobiol. 2011; 100: 107
- 1c Weireb O, Amit T, Bar-Am O, Youdim MB. H. Int. Rev. Neurobiol. 2011; 100: 191
- 2a Chahine LM, Stern MB. Int. Rev. Neurobiol. 2011; 100: 151
- 2b Weinreb O, Amit T, Riederer P, Youdim MB. H, Mandel SA. Int. Rev. Neurobiol. 2011; 100: 127
- 2c Bar-Am O, Weinreb O, Amit T, Youdim MB. H. J. Neurochem. 2010; 112: 1131
- 2d Youdim MB. H, Fridkin M, Zheng H. Mech. Ageing Dev. 2005; 126: 317
- 2e Youdim MB. H, Amit T, Bar-Am O, Weinstock M, Yogev-Falach M. Ann. N.Y. Acad. Sci. 2003; 993: 378
- 2f Youdim MB. H, Weinstock M. Mech. Ageing Dev. 2002; 123: 1081
- 2g Zheng H, Gal S, Weiner LM, Bar-Am O, Warshawsky A, Fridkin M, Youdim MB. H. J. Neurochem. 2005; 95: 68
- 2h Zhu W, Xie W, Pan T, Jankovic J, Li J, Youdim MB. H, Le W. J. Neurochem. 2008; 105: 1970
- 2i Am OB, Amit T, Youdim MB. H. Neurosci. Lett. 2004; 355: 169
- 2j Barac YD, Bar-Am O, Liani E, Amit T, Frolou L, Ovcharenko E, Angel I, Youdim MB. H, Binah O. PLoS One 2012; 7: e47890
- 2k Meier-Davis SR, Dines K, Arjmand FM, Hamlin R, Huang B, Wen J, Christianson C, Shudo J, Nagata T. Cutan. Ocul. Toxicol. 2012; 31: 312
- 3 Cymerman Craig J, Purushothaman KK. J. Org. Chem. 1970; 35: 1721
- 4a Youssif S. ARKIVOC 2001; (i): 242
- 4b Robison MM. J. Am. Chem. Soc. 1958; 80: 6254
- 4c Lyle MP. A, Narine AA, Wilson PD. J. Org. Chem. 2004; 69: 5060
- 4d Lyle MP. A, Draper ND, Wilson PD. Org. Biomol. Chem. 2006; 4: 877
- 4e Andreotti D, Miserazzi E, Nalin A, Pozzan A, Profeta R, Spada S. Tetrahedron Lett. 2010; 51: 6526
- 4f Li J. Name Reactions in Heterocyclic Chemistry. Li J.-J, Corey EJ. John Wiley and Sons; Hoboken: 2005
- 5 Omura K, Swern D. Tetrahedron 1978; 34: 1651
- 6 Abdel-Magid AF, Carson KG, Harris BD, Maryanoff CA, Shah RD. J. Org. Chem. 1996; 61: 3849
- 7 Selected 1H NMR and HRMS Data Compound 1: 1H NMR (400 MHz, CDCl3): δ = 2.09–2.16 (1 H, m), 2.32–2.39 (1 H, m), 2.42 (1 H, t, J = 2.4 Hz, OCH2CCH), 2.77 (1 H, ddd, J 1 = 4.6 Hz, J 2 = 8.7 Hz, J 3 = 13.3 Hz), 3.00–3.08 (1 H, m), 4.38 (1 H, dd, J 1 = 2.4 Hz, J 2 = 15.6 Hz, OCHHCCH), 4.46 (1 H, dd, J 1 = 2.4 Hz, J 2 = 15.7 Hz, OCHHCCH) 4.98 (1 H, dd, J 1 = 3.7 Hz, J 2 = 7.0 Hz), 7.10 (1 H, dd, J 1 = 4.9 Hz, J 2 = 7.6 Hz, Harom), 7.51 (1 H, dd, J 1 = 0.6 Hz, J 2 = 7.6 Hz, Harom), 8.39 (1 H, d, J = 4.9 Hz, Harom). ESI-HRMS: m/z calcd for [C11H11NO + H]+: 174.0913 [M + H+]; found: 174.0917. Compound 2: 1H NMR (400 MHz, CDCl3): δ = 1.87–2.03 (m + br s, 1 H + NHCHHCCH), 2.26 (1 H, t, J = 2.4 Hz, NHCHHCCH), 2.45–2.53 (1 H, m), 2.84–2.92 (1 H, m), 2.91 (1 H, ddd, J 1 = 3.8 Hz, J 2 = 8.8 Hz, J 3 = 12.7 Hz), 3.58 (1 H, dd, J 1 = 2.3 Hz, J 2 = 17.0 Hz, NHCHHCCH), 3.72 (1 H, dd, J 1 = 2.4 Hz, J 2 = 17.0 Hz, NHCHHCCH), 4.42 (1 H, t, J = 7.0 Hz), 7.12 (1 H, dd, J 1 = 5.0 Hz, J 2 = 6.9 Hz, Harom), 7.55 (1 H, d, J = 7.6 Hz, Harom), 8.42 (1 H, d, J = 4.9 Hz, Harom). ESI-HRMS: m/z calcd for [C11H12N2 + H]+: 173.1073 [M + H+]; found: 173.1072. Compound 3: 1H NMR (400 MHz, CDCl3): δ = 2.22 (2 H, t, J = 2.4 Hz, 2 × NHCHHCCH), 2.23–2.40 (2 H, m), 2.77–2.85 (1 H, m), 3.01 (1 H, ddd, J 1 = 5.1 Hz, J 2 = 8.6 Hz, J 3 = 13.7 Hz), 3.70 (2 H, dd, J 1 = 2.4 Hz, J 2 = 16.9 Hz, 2 × NHCHHCCH), 3.83 (2 H, dd, J 1 = 2.4 Hz, J 2 = 16.9 Hz, 2 × NHCHHCCH), 4.44 (1 H, t, J = 6.7 Hz), 7.11 (1 H, dd, J 1 = 4.9 Hz, J 2 = 7.6 Hz, Harom), 7.52 (1 H, dd, J 1 = 1.3 Hz, J 2 = 7.6 Hz, Harom), 8.45 (1 H, d, J = 4.2 Hz, Harom). ESI-HRMS: m/z calcd for [C14H14N2 + H]+: 211.1230 [M + H+]; found: 211.1224.